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Ferulic acid (4-hydroxy-3-methoxycinnamic acid), a phenolic
compound present in several plants, is an important pharmaceu-
tically active agent in the treatment of leukopenia and in providing
protection against cardiovascular and cerebrovascular disease. In
animal studies, ferulic acid was found to attenuate the decrease in
parvalbumin expression1 and prevent the decrease in Akt phos-
phorylation of Bad induced by focal cerebral ischemic injury2. It
has also been shown to possess antiatherogenic3, antidepressant4
and antioxidant5 properties.
A reference material (RM) is a material sufﬁciently homogeneous
and stable with respect to one or more speciﬁed properties that have
been established as ﬁt for its intended use in a measurement process. A
certiﬁed reference material (CRM) is an RM characterized by a
metrologically valid procedure for one or more speciﬁed properties
accompanied by a certiﬁcate that provides the value of the speciﬁed
property, the associated uncertainty and a statement of metrological
traceability6. Whilst it is generally agreed that CRMs are crucial to the
development of assays required for clinical chemistry and pharmaceu-
tical analysis, the number of commercially available CRMs is very
limited. In fact, an analysis by Nogueira et al.7, revealed that only a few
CRMs are available for purchase in the USA and Japan. In China,
many research institutions are engaged in the development of CRMs,
but compared with the number of marketed drugs and related medical
products, the number of CRMs remains very low.
In drug quality control, CRMs are important to ensure the purity of
drugs and provide conﬁdence in their efﬁcacy and safety. This in turn
requires reliable analytical methods that are not only accurate but also
ensure the traceability of the purity values of CRMs. The International
Organization for Standardization (ISO) Guideline 34, General require-
ments for the competence of reference material producers8, recom-
mends that the appropriate approach to drug characterization should be
selected based on the type of CRM and its intended use, the
competence of the laboratory involved and the quality of methods
employed. In addition, ISO Guideline 35, Reference materials–
General and statistical principles for certiﬁcation9, recommends that
a laboratory employs two or more independent methods when
assessing the purity of a particular CRM.
In the present study, three techniques based on different principles
namely differential scanning calorimetry (DSC), the mass balance
(MB) method based on high pressure liquid chromatography (HPLC)
and coulometric titrimetry (CT) were compared in evaluating the purity
of ferulic acid CRM for the ﬁrst time. The uncertainty evaluation of the
three methods was carefully performed according to the ISO Guide to
the Expression of Uncertainty in Measurement (GUM)10.2. Material and methods
2.1. Materials
Ferulic acid CRM (GBW 09518) was obtained from the Institute
of Materia Medica, Chinese Academy of Medical Sciences &
Peking Union Medical College. Indium (GBW (E) 130182) and
arsenious acid solution (GBW 08666) were obtained from the
National Institute of Metrology, China.
2.2. Instrumentation
DSC was performed using a Mettler Toledo DSC1/700 equipped
with an autosampler. The general performance of the instrument,including heat ﬂow, temperature and enthalpy, was calibrated
monthly using indium and the programmed In Check method
stored in STARe software according to the instruction manual.
HPLC was performed on an Agilent 1260 system with a diode-
array detector (DAD). Weight loss on drying and sulfated ash were
determined using a Yiheng vacuum drying oven and mufﬂe
furnace, respectively. CT was conducted using a coulometric
titrator produced by Institute of Materia Medica, Chinese
Academy of Medical Sciences & Peking Union Medical College.
A Mettler Toledo XS-105 analytical balance was also used.
All instruments were subjected to mandatory annual calibration
by the National Institute of Metrology to ensure that all measure-
ments could be traced to the International System of Units (SI)
and that the uncertainty in every measurement was in a traceability
chain.
2.3. Methods
2.3.1. DSC
DSC can be performed rapidly with high precision and does not
require a previously characterized CRM11–13. Its application to
purity assessment is based on the heat of fusion of the sample and
on the melting point of the main component which is reduced in
the presence of impurities. In a eutectic system, the correlation
between melting point depression and the degree of impurity is
described by the van't Hoff equation in
xsi ¼
ΔHfFðT0T f Þ
RT20
¼QMFΔT
mRT20
ð1Þ
where xsi is the content of solid impurities in the sample, ΔHf is
the molar enthalpy of fusion of the main component, F is the
melted fraction, ΔT¼T0Tf is the depression of the melting point,
Q is the heat of fusion of the sample, m is its mass, R is the gas
constant and M the molar mass of the main component. Generally,
samples contain a few volatile impurities the content of which, xvi,
is calculated using
xvi%¼
m0m1
m0
 100 ð2Þ
where m0 is the initial mass of sample and m1 is the mass of
sample determined at constant weight after drying. The actual
purity is then calculated using
Purity%¼ 1–xsið Þ 1–xvið Þ  100 ð3Þ
DSC was performed under a constant atmosphere of high-purity
nitrogen at a ﬂow rate of 50 mL/min and heating rate of 0.5 K/min.
The instrument was cooled using a refrigerated cooling system (Huber
TC45, Germany). Approximately 3 mg of sample was weighed to
within 0.01 mg using a Mettler 40 μL aluminum crucible, hermetically
sealed with an appropriate aluminum lid and crimped. An empty
crucible and lid of the same type were used as reference.
2.3.2. The MB method
In assessing the purity of a CRM, the total of volatile impurities xvi
(water, solvent residues, etc.), organic impurities xoi, inorganic
impurities (sulphated ash xsa determined as loss on ignition to
constant weight) and main component should equal 100%.
Accordingly, purity is determined by subtracting total impurities
from 100% as expressed
Purity%¼ 1–xoið Þ 1–xvi–xsað Þ  100 ð4Þ
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and (6) respectively:
xoi ¼
Pn
i ¼ 1
Aoif oi
Amcfmc þ
Pn
i ¼ 1
Aoif oi
ð5Þ
xsa%¼
m3
m2
 100 ð6Þ
where Aoi and Amc are the chromatographic peak areas of the
organic impurities and main component respectively, fi and fmc are
the corresponding correction factors, m2 is the initial mass of
sample and m3 is the mass of sulfated ash. This method is accurate
and recommended by the World Health Organization (WHO)14,
European Pharmacopoeia15, International Pharmacopoeia16 and
the National Metrology Institute organized by the Bureau Inter-
national des Poids et Mesures17.
In this study, chromatography was carried out on an Agilent Eclipse
XDB-C18 column (150 mm 4.6 mm, 5 μm) using a mobile phase
composed of aqueous 0.5% acetic acid:acetonitrile 85:15 (v/v)
delivered at 1 mL/min. The injection volume was 10 μL, column
temperature 30 1C and detection wavelength 320 nm. Volatile impu-
rities and inorganic impurities were determined as indicated above.2.3.3. CT
CT is an important method of electrochemical analysis based on
Faraday's law of electrolysis18. Here the relationship between
reactive substances and consumption of electricity is described byO
OH
O
OH
O
OH
O
OH
Br
Br
Br2
Figure 1 The addition reaction between ferulic acid and bromine in
the coulometric titration.
Table 1 Purity of ferulic acid CRM determined by DSC, MB meth
Measurement Purity
DSC (%) MB (%) CT (
1 99.94 99.97 99.8
2 99.91 99.97 99.8
3 99.98 99.98 99.7
4 99.97 99.97 99.8
5 99.96 99.91 99.7
6 99.92 99.97 99.8
7 99.91 99.96 99.7
8 99.95 99.92 99.8
9 99.94 99.96 99.8
10 99.96 99.95 99.8
Mean 99.94 99.96 99.8
SD 0.000246 0.000232 0.0W ¼QM
nF
¼ i t M
n F ð7Þ
where W is the weight (g) of reacting substance, Q is the electricity
through the electrode (the product of current i and time t), M is the
molar mass of the reactive substance, F is the Faraday constant
and n is the number of transferring electrons. Therefore, the purity
of the sample can be calculated using
Purity%¼ Wcal
W real
 100¼ QM
n F =C  V1
 
 100
¼ i t M
n F =
m4
V2
 V1
 
 100 ð8Þ
where Wcal is the amount (g) of reactive substance, Wreal is the amount
(g) of sample, C is the concentration (g/μL) of the reactive substance
(equal to its mass m4 divided by the volume (V2 μL) of the sample
solution) and V1 is the injection volume (μL) of the sample.
Purity determination of ferulic acid by CT is based on the
reaction between its carbon-carbon double bond and bromine
produced from the KBr electrolyte. The reaction shown in Fig. 1
involves the transfer of 2 electrons. In this study, the working and
indicator electrodes were platinum and the electrolyte solution was
KBr (4 mol/L) and HCl (8 mol/L) in a 1:1 ratio. The generator
current was 0.9985 mA and calibration was performed using a
solution of arsenious acid. The end point of the titration was
indicated by the increase in current.
2.4. Measurement uncertainty
2.4.1. DSC
According to the GUM and Eq. (3), the combined standard
uncertainty of purity determined by DSC can be calculated using
u2DSCðpurityÞ ¼
∂f
∂xsi
ucðxsiÞ
 2
þ ∂f
∂xvi
ucðxviÞ
 2
ð9Þ
u2DSCðpurityÞ  u2cðxsiÞ þ u2cðxviÞ ð10Þ
where uc(xsi) and uc(xvi) are calculated using Eqs. (11) and (12)
respectively:
ucðxsiÞ
xsi
 2
¼ ucðQÞ
Q
 2
þ ucðMÞ
M
 2
þ ucðFÞ
F
 2
þ ucðΔTÞ
ΔT
 2od, CT and levels of volatile and inorganic impurities.
Impurity
%) Loss on drying (%) Sulphated ash (%)
8 0.16 0.06
3 0.12 0.04
7 0.16 0.06
2 0.14 0.04
7 0.08 0.06
3 0.18 0.04
7 0.14 0.06
2 0.11 0.04
3 0.15 0.04
2 0.20 0.04
8 0.13 0.04
00347 0.000343 0.000103
Figure 2 The DSC curve of ferulic acid CRM.
Figure 3 The HPLC-DAD chromatogram of ferulic acid CRM.
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m
 2
þ ucðT0Þ
T0
 2
þ ucðf 1Þ
f 1
 2
ð11Þ
ucðxviÞ ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
∂ðxviÞ
∂m0
 2
Uðum0Þ2 þ
∂ðxviÞ
∂m1
 2
U ðum1Þ2
s
¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
m1
m02
 2
Uðum0Þ2 þ 
1
m0
 2
Uðum1Þ2
s
ð12Þ
Here f1 is the correction factor which mainly includes the linear
regression and integration performed by the software for purity
analysis.2.4.2. The MB method
On HPLC-MS analysis, it was found that the amounts of
impurities in the sample were too low to be identiﬁed. Therefore
it was assumed that foi¼ fmc and Eq. (5) becomes
xoi ¼
Pn
i ¼ 1
Aoi
Amc þ
Pn
i ¼ 1
Aoi
¼
Pn
i ¼ 1
Aoi
Atot
ð13Þ
where Atot is the chromatographic peak area of all components
archived form the Agilent workstation software.
According to the GUM and Eq. (4), the combined standard
uncertainty of purity determined by the MB method uMB can be
calculated using
u2MBðpurityÞ ¼
∂f
∂xoi
ucðxoiÞ
 2
þ ∂f
∂xvi
ucðxviÞ
 2
þ ∂f
∂xsa
ucðxsaÞ
 2
ð14Þ
u2MBðpurityÞ  u2c ðxoiÞ þ u2cðxviÞ þ u2cðxsaÞ ð15Þwhere uc(xoi) and uc(xsa) are in turn determined using Eq. (16) and
(17):
ucðxoiÞ
xoi
 2
¼ ucðAoiÞ
Aoi
 2
þ ucðAtotÞ
Atot
 2
þ ucðf 2Þ
f 2
 2
ð16Þ
ucðxsaÞ ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
∂ðxsaÞ
∂m2
 2
U ðum2Þ2 þ
∂ðxsaÞ
∂m3
 2
Uðum3Þ2
s
¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1
m2
 2
Uðum2Þ2 þ
m3
m22
 2
Uðum3Þ2
s
ð17Þ
Here f2 is the correction factor which mainly includes the
integration performed by the software for purity analysis.2.4.3. CT
According to the GUM and Eq. (8) and given that n and F are
constants in Eq. (8), the combined standard uncertainty of purity
Figure 4 Possible sources and contributions to uncertainty in the purity determination of ferulic acid CRM by DSC.
Table 2 Quantiﬁcation of the relevant uncertainties in the determination of the purity of ferulic acid CRM by DSC, MB method and CT.
Method Parameter
DSC uc(Q)/Q uc(M)/M uc(F)/F uc(ΔT)/ΔT uc(m)/m uc(T0)/ T0 uc(f1)/f1 uc(xvi)/xvi
8.60 104 2.41 105 7.08 101 8.04 102 2.49 102 8.76 104 2.27 101 4.35 101
MB method uc(Aoi)/Aoi uc(Atot)/Atot uc(f2)/f2 uc(xvi)/xvi uc(xsa)/xsa
1.68 101 4.03 103 1.83 101 4.35 101 1.15
CT uc(i)/i uc(t)/t uc(M)/M uc(m4)/m4 uc(V1)/V1 uc(V2)/V2 uc(f3)/f3
5.28 104 2.77 104 2.41 105 5.52 104 5.10 104 3.27 104 2.40 106
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uCTðpurityÞ
Purity
 2
 ucðiÞ
i
 2
þ ucðtÞ
t
 2
þ ucðMÞ
M
 2
þ ucðm4Þ
m4
 2
þ ucðV1Þ
V1
 2
þ ucðV2Þ
V2
 2
þ ucðf 3Þ
f 3
 2
ð18Þ
where f3 is the correction factor which mainly includes the uncertainty
in the current calibration of the coulometric titrator used in this study.
2.4.4. Expanded measurement uncertainty
When the measurement uncertainty is evenly distributed and the
conﬁdence interval is 0.95, the coverage factor k of the extended
measurement uncertainty U is 2. Therefore, in the present study,
the expanded measurement uncertainty U of these methods was
calculated using
Umethod ¼ umethodðpurityÞ  2 ð19Þ
3. Results
The purities and impurities determined using the different methods
are listed in Table 1. Data from each method were analyzed using
Gravel booth inspection and no outliers were found. The results
obtained by DSC, the MB method and CT were not signiﬁcantly
different based on Students t-tests.
3.1. DSC
The heat ﬂow temperature curve and plot of Tf versus 1/F for DSC
of ferulic acid CRM are shown in Fig. 2. As indicated by Eq. (1),
data for the latter ﬁts well to a straight line. The purity of the
sample determined by DSC according to Eq. (3) was 99.81%. The
combined standard uncertainty calculated using Eqs. (9)–(12) was
0.08% giving a U value of 0.16% (k¼2, P¼95%).3.2. The MB method
A typical HPLC chromatogram of ferulic acid CRM is shown in
Fig. 3. The main peak at 9.362 min indicates ferulic acid and the
peak at 7.297 min is clearly due to an impurity. The purity of the
sample determined using the MB method according to Eq. (4) was
99.79%. The combined standard uncertainty calculated using Eqs.
(14)–(17) was 0.08% giving a U value of 0.16% (k¼2, P¼95%).
3.3. CT
The purity of the sample determined by CT according to Eq. (8)
was 99.81%. The combined standard uncertainty calculated
according to Eq. (18) was 0.13% giving a U value of 0.26%
(k¼2, P¼95%).4. Discussion
4.1. DSC
Purity determination by DSC depends on the heating rate of the
instrument which according to the American Society for Testing
and Materials (ASTM) E 928-0819 should be in the range 0.3–
0.7 K/min. Using different heating rates in this range indicated that
heating rate has no signiﬁcant effect on purity determination and
accordingly the heating rate was set to 0.5 K/min.
Several factors may affect the results of purity determination by
DSC. Here the possible sources of uncertainty in the DSC method
were carefully identiﬁed and calculated based on Guideline CG 4
of the Eurachem/Citac working group: Quantifying uncertainty in
analytical measurement20. The relevant sources of uncertainty and
their contributions to purity determination by DSC are shown in
Fig. 4 and the results are shown in Tables 1 and 2.
Dezhi Yang et al.2364.2. The MB method
The MB method is commonly used to assess sample purity and is
generally applied as HPLC with mass spectrometry (MS) to
identify impurities. However, in this study impurities in the
sample produced no signal in MS despite investigating the effectFigure 6 Possible sources and contributions to uncertainty
Figure 5 Possible sources and contributions to uncertainty in theof increasing sample concentration and chromatographic run time
and the use of gradient elution and multi-wavelength detection. As
a result, the correction factor for each impurity could not be
determined and purity was assessed by HPLC with UV detection.
As for DSC, the possible sources of uncertainty in the MB
method were identiﬁed and quantiﬁed based on Guideline CG 4 ofin the purity determination of ferulic acid CRM by CT.
purity determination of ferulic acid CRM by the MB method.
Ferulic acid CRM for pharmaceutical analysis 237the Eurachem/Citac working group20. The sources of uncertainty
and their contributions to purity determination are shown in Fig. 5
and the results in Tables 1 and 2.
4.3. CT
The limitation of this method is that organic impurities containing
unsaturation (double bonds, activated benzene rings) can also
undergo addition reactions with bromine and bias the results.
However, a previous study showed that the destruction experiment
does not produce any degradation products in the sample.
The possible sources of uncertainty in the CT method were
carefully identiﬁed and are shown in Fig. 6. The corresponding
uncertainties were calculated and are given in Tables 1 and 2.5. Conclusions
In this study, three analytical techniques based on different
principles were used to determine the purity of ferulic acid
CRM for the ﬁrst time. Consistent results were obtained providing
conﬁdence in the purity assessment. CT and DSC have the
advantages of practicality, speed and reproducibility and do not
require a previously characterized reference standard. However,
they have a narrow working range which limits their applicability
for purity determination. They therefore act as complementary
techniques to the MB method for substances that react with
bromine (CT) or for detecting impurities which can form a eutectic
mixture with the principal component (DSC).
Ferulic acid CRM has been approved and assigned as a primary
reference material by the General Administration of Quality
Supervision, Inspection, and Quarantine of the People's Republic
of China. The CRM number is GBW 09518, and its purity is
99.8% with an expanded uncertainty of 0.5% (k¼2, P¼0.95).
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